Eubiotics Market Size, Share & Industry Analysis, By Product Type (Prebiotics, Probiotics, Organic Acids, Phytogenics, Synbiotics, Enzymes, and Others), By Form (Dry and Liquid), By Function (Gut Health & Nutrition, Yield & Performance, Immunity, and Others), By Livestock (Poultry, Swine, Ruminants, Aquaculture, and Others), and Regional Forecast, 2026-2034

The global eubiotics market size was valued at USD 8.71 billion in 2025. The market is projected to grow from USD 9.26 billion in 2026 to USD 16.18 billion by 2034, exhibiting a CAGR of 7.23% during the forecast period.

Eubiotics are feed additives and gut-health solutions used to improve intestinal microbial balance, nutrient utilisation, animal performance, and health outcomes across poultry, swine, ruminants, and aquaculture systems. The category generally includes prebiotics, probiotics, organic acids, phytogenics, synbiotics, enzymes, and related gut-health additives. Their strategic importance has increased as livestock and aquaculture producers seek better feed conversion, pathogen control, immunity support, and antibiotic-reduction strategies in commercial production systems.

The market is supported by leading animal nutrition and feed formulators companies such as DSM-Firmenich, Cargill, Incorporated, Archer Daniels Midland Company, Evonik Industries AG, Novonesis, and Kemin Industries, Inc. These companies maintain active positions in animal nutrition, gut health, probiotics, enzymes, and speciality feed solutions.

Eubiotics Market Trends

Increasing Shift Toward Antibiotic-Free Animal Nutrition to Shape Industry Trends

A major trend in the global market is the growing shift toward antibiotic-free animal production systems. Livestock producers are increasingly adopting eubiotics such as probiotics, phytogenics, and organic acids to maintain gut health and improve feed conversion efficiency without relying on antibiotic growth promoters. This transition is particularly evident in the poultry and swine industries, where regulatory restrictions and consumer demand for antibiotic-free meat are driving innovation.

Additionally, the market is witnessing increased development of multi-functional and combination products, such as synbiotics, which combine prebiotics and probiotics for enhanced efficacy. The integration of precision nutrition and microbiome-based solutions is further transforming the market, enabling producers to optimise animal health and productivity under varying environmental and operational conditions.

• According to the European Medicines Agency, veterinary antibiotic sales in 25 European countries fell by 53% between 2011 and 2022, reaching the lowest level ever reported under EMA surveillance. This was one of the clearest quantitative indicators of a structural move toward lower-antibiotic livestock production and feed management systems.

MARKET DYNAMICS

Market Drivers

Download Free sample to learn more about this report.

Steady Expansion of Livestock Production to Support Market Growth

The global eubiotics market growth is being significantly supported by the steady expansion of livestock production and compound feed output across key agricultural economies. As the production of meat, milk, eggs, and aquaculture products increases, the demand for high-quality animal-formulated feed solutions that enhance animal health, nutrient absorption, and production efficiency is also rising. In this context, eubiotics products have emerged as an essential category of feed additives, owing to their ability to promote gut health, improve feed conversion efficiency, strengthen immunity, and support sustainable livestock performance.

• According to the Food and Agriculture Organisation (FAO), global meat production reached approximately 374 million tons in 2024, while milk production approached 985 million tons, highlighting strong growth in animal protein demand. Additionally, global feed production exceeded 1.3 billion metric tons, reflecting the expanding industrial feed sector.

Market Restraints

Variability in Product Performance and Regulatory Complexity to Limit Market Expansion

The growth of the market is being constrained by the inconsistent field performance of certain products across animal species, production environments, feed formulations, and farm-management conditions. Unlike conventional nutritional raw material that typically shows more standardised response patterns, the efficacy of eubiotics such as probiotics, prebiotics, phytogenics, organic acids, and yeast-based products can vary significantly depending on dosage, strain specificity, animal age, gut-health status, feed composition, biosecurity conditions, and environmental stress. This variability creates hesitation among feed manufacturers and livestock producers, particularly when a consistent return on investment is not demonstrated under commercial farming conditions.

The regulatory environment reinforces this challenge, as authorities in major markets require product-specific evidence of safety and efficacy before approval or renewal.

• For instance, the European Commission maintains a continuously updated EU Register of Feed Additives, reflecting a highly structured authorization and reauthorization regime. For eubiotics suppliers, this regulatory framework necessitates extensive technical documentation, scientific substantiation, and continuous compliance management across species and usage claims, thereby increasing development costs and extending commercialization timelines.

Market Opportunities

Rising Adoption of Functional Feed Solutions to Present Several Growth Opportunities

The expanding global aquaculture sector is expected to create substantial growth opportunities for the market, as fish and shrimp producers increasingly adopt functional feed solutions to improve animal health, feed efficiency, survival rates, and production consistency. Aquaculture has become one of the most dynamic segments within animal protein production, and this structural expansion is strengthening demand for scientifically formulated feed additives that can support gut health, disease resilience, nutrient absorption, and environmental performance in aquatic species. In this context, eubiotics are gaining strategic traction as aquaculture producers seek sustainable alternatives to conventional health-management approaches, aiming to enhance biological performance under intensive farming systems.

• According to FAO’s State of World Fisheries and Aquaculture 2024 report, global aquaculture production reached a record 130.9 million tons in 2022, valued at approximately USD 313 billion. Of this total, 94.4 million tons came from aquatic animals, and aquaculture accounted for 51% of global aquatic animal production.

SEGMENTATION ANALYSIS

By Product Type

Organic Acids Segment Dominated the Market Due to Its Wide Use in Reducing Gut pH

Based on product type, the market is segmented into prebiotics, probiotics, organic acids, phytogenics, synbiotics, enzymes, and others.

The organic acids segment dominated the global eubiotics market share, securing USD 2.42 billion in 2025, as these additives are widely used to reduce gut pH, improve feed hygiene, suppress harmful microbial growth, and support digestive stability across poultry and swine production.

The synbiotics segment is projected to grow at a CAGR of 8.99% during the global forecast period, driven by the rising use of combined prebiotic and probiotic solutions for stronger gut-health outcomes.

To know how our report can help streamline your business, Speak to Analyst

By Form

Dry Segment Dominated the Market Due to Its Widespread Usage In Premixes And Compound Feed Formulations

Based on form, the market is segmented into dry and liquid.

The dry segment dominated the global market, valued at USD 7.26 billion in 2025, owing to its ease of handling, storage convenience, lower transportation cost, and wide use in premixes and compound feed formulations.

The liquid segment is expected to grow at the fastest CAGR of 8.25% during the forecast period, supported by rising use in drinking-water applications, farm-level dosing systems, and flexible livestock nutrition programs.

By Function

Growing Usage of Eubiotics to Improve Intestinal Balance Boosted Gut Health & Nutrition Segment Growth

Based on function, the market is segmented into gut health & nutrition, yield & performance, immunity, and others.

The gut health & nutrition segment dominated the market, reaching USD 3.74 billion in 2025, as eubiotics are primarily used to improve intestinal balance, nutrient uptake, feed conversion, and overall digestive performance.

The immunity segment is projected to grow at a CAGR of 8.26%, driven by increasing focus on disease resistance, animal resilience, and reduced dependence on antibiotic-based interventions.

By Livestock

High Production Volumes and Intensive Feed Programs Supported Poultry Segment Growth

Based on livestock, the market is segmented into poultry, swine, ruminants, aquaculture, and others.

The poultry segment dominated the market, securing USD 3.08 billion in 2025, supported by high production volumes, intensive feed programs, and strong adoption of acidifiers, probiotics, enzymes, and phytogenics to improve feed conversion and gut performance.

The aquaculture segment is projected to grow at a CAGR of 9.03% from 2026 to 2034, driven by rising demand for functional aquafeed, disease management, and improved feed efficiency in farmed fish and shrimp production.

Eubiotics Market Regional Outlook

Regionally, the market is studied across North America, Europe, Asia Pacific, South America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America was valued at USD 1.84 billion in 2025 and is projected to reach USD 3.27 billion by 2034, growing at a CAGR of 6.71%. Growth is driven by advanced feed manufacturing systems and increasing adoption of antibiotic alternatives.

U.S. Eubiotics Market

The U.S. dominates the North American market, valued at approximately USD 1.46 billion in 2025. The dominance is supported by large-scale poultry and livestock production and a strong regulatory push toward antibiotic reduction.

Europe

Europe was valued at 2.17 billion in 2025 and is projected to reach USD 3.70 billion by 2034, growing at a CAGR of 6.17%. The region benefits from strict antibiotic regulations and early adoption of the product.

Germany Eubiotics Market

Germany was valued at approximately USD 0.49 billion in 2025. The growth of the country is driven by its strong feed industry and livestock production base.

U.K. Eubiotics Market

The U.K.’s market was valued at approximately USD 0.33 billion in 2025, due to increasing demand for sustainable animal nutrition solutions.

Asia Pacific

Asia Pacific dominated the global market, valued at USD 3.23 billion in 2025, and is projected to reach USD 6.47 billion by 2034, growing at a CAGR of 8.13%. Growth of the region is driven by expanding livestock production and rising feed demand.

China Eubiotics Market

China dominated the regional market, valued at approximately USD 1.33 billion in 2025, due to its large livestock and feed industry.

India Eubiotics Market

India was valued at USD 0.45 billion in 2025. India is emerging as a high-growth market, supported by increasing poultry and dairy production.

South America and the Middle East & Africa

South America was valued at USD 0.98 billion in 2025 and is projected to reach USD 1.81 billion by 2034, growing at a CAGR of 7.17%. Growth in the region is driven by strong poultry and beef production, expanding feed manufacturing capacity, and increasing adoption of feed efficiency solutions in export-oriented livestock industries.

The Middle East & Africa market was valued at USD 0.49 billion in 2025 and is projected to reach USD 0.94 billion by 2034, growing at a CAGR of 7.56%. Growth is supported by rising poultry consumption, increasing investments in commercial livestock farming, and improving feed industry infrastructure across key markets.

Brazil Eubiotics Market

Brazil dominated the regional market, valued at approximately USD 0.53 billion in 2025, supported by its strong poultry and beef production industry.

COMPETITIVE LANDSCAPE

Key Industry Players

Key Players Focus on Investment to Improve Animal Performance

Key players in the global eubiotics market focus on innovation in gut-health solutions, microbial technologies, and feed efficiency optimization. Companies are investing in enzyme engineering, probiotic strain development, product development, and integrated feed additive solutions to enhance animal performance and reduce reliance on antibiotics. Strategic expansion, partnerships with feed manufacturers, and development of species-specific formulations remain central to competitive positioning in the market.

Key Players in the Eubiotics Market

List of Key Eubiotics Companies Profiled

• dsm-firmenich (Switzerland)
• Cargill, Incorporated (U.S.)
• Archer Daniels Midland Company (U.S.)
• Evonik Industries AG (Germany)
• Novonesis (Denmark)
• Kemin Industries (U.S.)
• Alltech Inc. (U.S.)
• BASF SE (Germany)
• Novus International, Inc. (U.S.)
• Lallemand Inc. (Canada)

KEY INDUSTRY DEVELOPMENTS

• March 2026: Huvepharma launched Huvezym neXo as a novel fibre-degrading enzyme complex for pigs and poultry feed. This enzyme combines two cellulases and a potent 1,4-beta-xylanase to break down complex fibre structures in diets with high-fibre or alternative ingredients such as maize, barley, soybean, and byproducts.
• December 2025: Orffa launched its Elovital-branded portfolio of amino acids and vitamins at Poultry India 2025 in Hyderabad, targeting poultry, aquaculture, and livestock producers in South Asia. This expansion enhances Orffa's offerings with high-quality, science-backed feed additives for better consistency and efficiency in fast-growing markets.
• January 2025: Evonik launched Ecobiol Soluble Plus, a water-soluble probiotic for poultry, at the 16th Poultry India event in Hyderabad. This innovation from Evonik targets sustainable poultry production by enhancing gut health, nutrient absorption, and resistance to pathogens using Bacillus amyloliquefaciens CECT 5940.
• December 2024: Canada‑based animal‑nutrition company Novibio Inc. launched Poultrirom Plus, a new product designed to enhance intestinal health in broilers and turkeys.
• December 2021: DSM-Firmenich acquired Midori USA, Inc., a biotech start-up with a next-generation eubiotics platform. The company already owns 38.5% of the shares of Midori and bought the remaining 61.5% share for USD 63 million. This complemented DSM's eubiotics portfolio, bolstered by its prior Biomin acquisition.

REPORT COVERAGE

The global eubiotics market industry report analyses the market in depth and highlights crucial aspects such as global market trends, market dynamics, supply chains, prominent companies, investment in research and development, and end-use. Besides this, the report also provides insights into the global market analysis and highlights significant industry developments.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation